Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant
Status: | Terminated |
---|---|
Conditions: | Other Indications, Other Indications |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | Any |
Updated: | 5/27/2018 |
Start Date: | March 2004 |
End Date: | February 2017 |
Longitudinal Efficacy in Young Children Implanted Bilaterally With MED-EL COMBI 40+ / PULSARCI100/SONATATI100 Cochlear Implant Systems.
The purpose of this study is to evaluate and document longitudinal efficacy in young children
implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant
systems.
implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant
systems.
Inclusion Criteria:
- Between 12 and 36 months of age at time of implantation
- Profound bilateral sensorineural hearing loss
- English as the primary language in the home
- Realistic expectations of guardians
- Child must be enrolled in a post-operative rehabilitative/educational program that
supports the use of cochlear implants and the development of auditory-based skills
- Willing and available to comply with all scheduled procedures as defined in the
protocol
Audiological:
- Profound bilateral sensorineural hearing loss with average thresholds between ears of
90 dB HL or greater at 1000 Hz and above, and must demonstrate minimal functional
benefit from conventional amplification
- Behavioral test measures must include unaided threshold measures for the right and
left ears using insert earphones; left-alone and right-alone aided sound field
threshold measurements; and aided and unaided speech-awareness / detection thresholds
(for each ear individually)
- Children accepted into the study must be able to demonstrate a consistent response to
sound. If a child has no measurable hearing, he/she must be able to demonstrate a
consistent response to vibrotactile stimuli.
- All children must have completed an appropriate trial period with optimally fit
amplification prior to inclusion in the study.
Medical:
- Good general health status, as judged by Primary Investigator
- Patent cochleae bilaterally, as indicated by radiological evaluation
- No contraindications for surgery, in general, or cochlear implant surgery in
particular
Exclusion Criteria:
- Prior experience with any cochlear implant system
- Younger than 12 months or older than 36 months at time of implantation
- Audiological: Presence of otoacoustic emissions and/or cochlear microphonic,
indicating possible condition of auditory neuropathy
Medical:
- Evidence of ossification that would prevent full insertion of the standard C40+ /
PULSARCI100 /SONATATI100 electrode array in the cochlea(e) to be implanted, as
indicated by radiological evaluation
- Abnormal or malformed cochlea(e) to be implanted
- Severed or non-functional auditory nerve in the ear(s) to be implanted
- Central auditory lesion
- Cognitive and/or neurological dysfunction
- Auditory neuropathy
We found this trial at
9
sites
Children's Healthcare of Atlanta Whether treating a toddler in an emergency or supporting a teen...
Click here to add this to my saved trials
Click here to add this to my saved trials
Nemours Children's Clinic At Nemours Children’s Clinic, Jacksonville, we've treated every child as we would...
Click here to add this to my saved trials
Click here to add this to my saved trials
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
Click here to add this to my saved trials
Click here to add this to my saved trials
Texas Children's Hospital Texas Children's Hospital, located in Houston, Texas, is a not-for-profit organization whose...
Click here to add this to my saved trials
Click here to add this to my saved trials
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
Click here to add this to my saved trials